)
)
CohBar Investor Relations Material
Latest events
M&A Announcement
CohBar
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from CohBar Inc
Access all reports
CohBar, Inc. is a clinical stage biotechnology company based in California that focuses on the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The Company's platform technology involves improving cellular metabolism to enhance healthy biological aging through encapsulation of mitochondria within multifunctional liposomes. Cohbar's sales channels are through direct sales and through distributors who are licensed to market its products both domestically and internationally.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
CWBR
Country
🇺🇸 United States